Accounts Receivables - MaxCyte Inc (NASDAQ:MXCT) - Alpha Spread
M

MaxCyte Inc
NASDAQ:MXCT

Watchlist Manager
MaxCyte Inc
NASDAQ:MXCT
Watchlist
Price: 4.06 USD -0.98%
Market Cap: 425.6m USD
Have any thoughts about
MaxCyte Inc?
Write Note

MaxCyte Inc
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

MaxCyte Inc
Accounts Receivables Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
M
MaxCyte Inc
NASDAQ:MXCT
Accounts Receivables
$5.8m
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Accounts Receivables
$9.4B
CAGR 3-Years
15%
CAGR 5-Years
18%
CAGR 10-Years
13%
Danaher Corp
NYSE:DHR
Accounts Receivables
$3.3B
CAGR 3-Years
-8%
CAGR 5-Years
-2%
CAGR 10-Years
-1%
Mettler-Toledo International Inc
NYSE:MTD
Accounts Receivables
$634.7m
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
4%
Agilent Technologies Inc
NYSE:A
Accounts Receivables
$1.2B
CAGR 3-Years
3%
CAGR 5-Years
7%
CAGR 10-Years
3%
IQVIA Holdings Inc
NYSE:IQV
Accounts Receivables
$3.3B
CAGR 3-Years
13%
CAGR 5-Years
6%
CAGR 10-Years
13%

See Also

What is MaxCyte Inc's Accounts Receivables?
Accounts Receivables
5.8m USD

Based on the financial report for Dec 31, 2023, MaxCyte Inc's Accounts Receivables amounts to 5.8m USD.

What is MaxCyte Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
3%

Over the last year, the Accounts Receivables growth was -58%. The average annual Accounts Receivables growth rates for MaxCyte Inc have been 4% over the past three years , 3% over the past five years .

Back to Top